Fidaxomicin Preserves the Intestinal Microbiome During and After Treatment of Clostridium difficile Infection (CDI) and Reduces Both Toxin Reexpression and Recurrence of CDI

por Louie, Thomas J., Cannon, Kris, Byrne, Brendan, Emery, Judy, Ward, Linda, Eyben, Melissa, Krulicki, Walter
Publicado 2012